Injection Peptide Drug Market, Global Outlook and Forecast 2024-2031

Report ID: 1658796 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Injection Peptide Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Injection Peptide Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Injection Peptide Drug Overall Market Size
    2.1 Global Injection Peptide Drug Market Size: 2021 VS 2028
    2.2 Global Injection Peptide Drug Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Injection Peptide Drug Players in Global Market
    3.2 Top Global Injection Peptide Drug Companies Ranked by Revenue
    3.3 Global Injection Peptide Drug Revenue by Companies
    3.4 Top 3 and Top 5 Injection Peptide Drug Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Injection Peptide Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Injection Peptide Drug Players in Global Market
        3.6.1 List of Global Tier 1 Injection Peptide Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Injection Peptide Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Injection Peptide Drug Market Size Markets, 2021 & 2028
        4.1.2 Intravenous Injection
        4.1.3 Subcutaneous Injection
    4.2 By Type - Global Injection Peptide Drug Revenue & Forecasts
        4.2.1 By Type - Global Injection Peptide Drug Revenue, 2017-2022
        4.2.2 By Type - Global Injection Peptide Drug Revenue, 2023-2028
        4.2.3 By Type - Global Injection Peptide Drug Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Injection Peptide Drug Market Size, 2021 & 2028
        5.1.2 Cancer
        5.1.3 Metabolic Disorders
        5.1.4 Central Nervous System
        5.1.5 Other
    5.2 By Application - Global Injection Peptide Drug Revenue & Forecasts
        5.2.1 By Application - Global Injection Peptide Drug Revenue, 2017-2022
        5.2.2 By Application - Global Injection Peptide Drug Revenue, 2023-2028
        5.2.3 By Application - Global Injection Peptide Drug Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Injection Peptide Drug Market Size, 2021 & 2028
    6.2 By Region - Global Injection Peptide Drug Revenue & Forecasts
        6.2.1 By Region - Global Injection Peptide Drug Revenue, 2017-2022
        6.2.2 By Region - Global Injection Peptide Drug Revenue, 2023-2028
        6.2.3 By Region - Global Injection Peptide Drug Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Injection Peptide Drug Revenue, 2017-2028
        6.3.2 US Injection Peptide Drug Market Size, 2017-2028
        6.3.3 Canada Injection Peptide Drug Market Size, 2017-2028
        6.3.4 Mexico Injection Peptide Drug Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Injection Peptide Drug Revenue, 2017-2028
        6.4.2 Germany Injection Peptide Drug Market Size, 2017-2028
        6.4.3 France Injection Peptide Drug Market Size, 2017-2028
        6.4.4 U.K. Injection Peptide Drug Market Size, 2017-2028
        6.4.5 Italy Injection Peptide Drug Market Size, 2017-2028
        6.4.6 Russia Injection Peptide Drug Market Size, 2017-2028
        6.4.7 Nordic Countries Injection Peptide Drug Market Size, 2017-2028
        6.4.8 Benelux Injection Peptide Drug Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Injection Peptide Drug Revenue, 2017-2028
        6.5.2 China Injection Peptide Drug Market Size, 2017-2028
        6.5.3 Japan Injection Peptide Drug Market Size, 2017-2028
        6.5.4 South Korea Injection Peptide Drug Market Size, 2017-2028
        6.5.5 Southeast Asia Injection Peptide Drug Market Size, 2017-2028
        6.5.6 India Injection Peptide Drug Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Injection Peptide Drug Revenue, 2017-2028
        6.6.2 Brazil Injection Peptide Drug Market Size, 2017-2028
        6.6.3 Argentina Injection Peptide Drug Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Injection Peptide Drug Revenue, 2017-2028
        6.7.2 Turkey Injection Peptide Drug Market Size, 2017-2028
        6.7.3 Israel Injection Peptide Drug Market Size, 2017-2028
        6.7.4 Saudi Arabia Injection Peptide Drug Market Size, 2017-2028
        6.7.5 UAE Injection Peptide Drug Market Size, 2017-2028
7 Players Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporate Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Injection Peptide Drug Major Product Offerings
        7.1.4 Sanofi Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.1.5 Sanofi Key News
    7.2 Teva
        7.2.1 Teva Corporate Summary
        7.2.2 Teva Business Overview
        7.2.3 Teva Injection Peptide Drug Major Product Offerings
        7.2.4 Teva Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.2.5 Teva Key News
    7.3 Novo Nordisk
        7.3.1 Novo Nordisk Corporate Summary
        7.3.2 Novo Nordisk Business Overview
        7.3.3 Novo Nordisk Injection Peptide Drug Major Product Offerings
        7.3.4 Novo Nordisk Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.3.5 Novo Nordisk Key News
    7.4 Takeda
        7.4.1 Takeda Corporate Summary
        7.4.2 Takeda Business Overview
        7.4.3 Takeda Injection Peptide Drug Major Product Offerings
        7.4.4 Takeda Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.4.5 Takeda Key News
    7.5 Eli Lilly
        7.5.1 Eli Lilly Corporate Summary
        7.5.2 Eli Lilly Business Overview
        7.5.3 Eli Lilly Injection Peptide Drug Major Product Offerings
        7.5.4 Eli Lilly Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.5.5 Eli Lilly Key News
    7.6 AstraZeneca
        7.6.1 AstraZeneca Corporate Summary
        7.6.2 AstraZeneca Business Overview
        7.6.3 AstraZeneca Injection Peptide Drug Major Product Offerings
        7.6.4 AstraZeneca Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.6.5 AstraZeneca Key News
    7.7 Novartis
        7.7.1 Novartis Corporate Summary
        7.7.2 Novartis Business Overview
        7.7.3 Novartis Injection Peptide Drug Major Product Offerings
        7.7.4 Novartis Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.7.5 Novartis Key News
    7.8 AbbVie
        7.8.1 AbbVie Corporate Summary
        7.8.2 AbbVie Business Overview
        7.8.3 AbbVie Injection Peptide Drug Major Product Offerings
        7.8.4 AbbVie Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.8.5 AbbVie Key News
    7.9 Ipsen
        7.9.1 Ipsen Corporate Summary
        7.9.2 Ipsen Business Overview
        7.9.3 Ipsen Injection Peptide Drug Major Product Offerings
        7.9.4 Ipsen Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.9.5 Ipsen Key News
    7.10 Ferring
        7.10.1 Ferring Corporate Summary
        7.10.2 Ferring Business Overview
        7.10.3 Ferring Injection Peptide Drug Major Product Offerings
        7.10.4 Ferring Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.10.5 Ferring Key News
    7.11 Merck
        7.11.1 Merck Corporate Summary
        7.11.2 Merck Business Overview
        7.11.3 Merck Injection Peptide Drug Major Product Offerings
        7.11.4 Merck Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.11.5 Merck Key News
    7.12 The Medicines
        7.12.1 The Medicines Corporate Summary
        7.12.2 The Medicines Business Overview
        7.12.3 The Medicines Injection Peptide Drug Major Product Offerings
        7.12.4 The Medicines Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.12.5 The Medicines Key News
    7.13 J & J
        7.13.1 J & J Corporate Summary
        7.13.2 J & J Business Overview
        7.13.3 J & J Injection Peptide Drug Major Product Offerings
        7.13.4 J & J Injection Peptide Drug Revenue in Global Market (2017-2022)
        7.13.5 J & J Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Injection Peptide Drug Market Opportunities & Trends in Global Market
    Table 2. Injection Peptide Drug Market Drivers in Global Market
    Table 3. Injection Peptide Drug Market Restraints in Global Market
    Table 4. Key Players of Injection Peptide Drug in Global Market
    Table 5. Top Injection Peptide Drug Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Injection Peptide Drug Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Injection Peptide Drug Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Injection Peptide Drug Product Type
    Table 9. List of Global Tier 1 Injection Peptide Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Injection Peptide Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Injection Peptide Drug Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Injection Peptide Drug Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Injection Peptide Drug Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Injection Peptide Drug Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Injection Peptide Drug Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Injection Peptide Drug Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Injection Peptide Drug Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Injection Peptide Drug Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Injection Peptide Drug Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
    Table 30. Sanofi Corporate Summary
    Table 31. Sanofi Injection Peptide Drug Product Offerings
    Table 32. Sanofi Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 33. Teva Corporate Summary
    Table 34. Teva Injection Peptide Drug Product Offerings
    Table 35. Teva Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 36. Novo Nordisk Corporate Summary
    Table 37. Novo Nordisk Injection Peptide Drug Product Offerings
    Table 38. Novo Nordisk Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 39. Takeda Corporate Summary
    Table 40. Takeda Injection Peptide Drug Product Offerings
    Table 41. Takeda Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 42. Eli Lilly Corporate Summary
    Table 43. Eli Lilly Injection Peptide Drug Product Offerings
    Table 44. Eli Lilly Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 45. AstraZeneca Corporate Summary
    Table 46. AstraZeneca Injection Peptide Drug Product Offerings
    Table 47. AstraZeneca Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 48. Novartis Corporate Summary
    Table 49. Novartis Injection Peptide Drug Product Offerings
    Table 50. Novartis Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 51. AbbVie Corporate Summary
    Table 52. AbbVie Injection Peptide Drug Product Offerings
    Table 53. AbbVie Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 54. Ipsen Corporate Summary
    Table 55. Ipsen Injection Peptide Drug Product Offerings
    Table 56. Ipsen Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 57. Ferring Corporate Summary
    Table 58. Ferring Injection Peptide Drug Product Offerings
    Table 59. Ferring Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 60. Merck Corporate Summary
    Table 61. Merck Injection Peptide Drug Product Offerings
    Table 62. Merck Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 63. The Medicines Corporate Summary
    Table 64. The Medicines Injection Peptide Drug Product Offerings
    Table 65. The Medicines Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
    Table 66. J & J Corporate Summary
    Table 67. J & J Injection Peptide Drug Product Offerings
    Table 68. J & J Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Injection Peptide Drug Segment by Type in 2021
    Figure 2. Injection Peptide Drug Segment by Application in 2021
    Figure 3. Global Injection Peptide Drug Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Injection Peptide Drug Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Injection Peptide Drug Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Injection Peptide Drug Revenue in 2021
    Figure 8. By Type - Global Injection Peptide Drug Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Injection Peptide Drug Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Injection Peptide Drug Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Injection Peptide Drug Revenue Market Share, 2017-2028
    Figure 12. US Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Injection Peptide Drug Revenue Market Share, 2017-2028
    Figure 16. Germany Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 17. France Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Injection Peptide Drug Revenue Market Share, 2017-2028
    Figure 24. China Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 28. India Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Injection Peptide Drug Revenue Market Share, 2017-2028
    Figure 30. Brazil Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Injection Peptide Drug Revenue Market Share, 2017-2028
    Figure 33. Turkey Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
    Figure 37. Sanofi Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Teva Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novo Nordisk Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Takeda Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Eli Lilly Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AstraZeneca Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Novartis Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AbbVie Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Ipsen Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Ferring Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Merck Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. The Medicines Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. J & J Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Injection Peptide Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Injection Peptide Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Injection Peptide Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports